• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高效液相色谱法、放射免疫分析法、荧光偏振免疫分析法。万古霉素测定3种方法的评估]

[HPLC, RIA, FPIA. Evaluation of 3 methods for the assay of vancomycin].

作者信息

Jehl F, Monteil H, Gallion C, Thierry R C

出版信息

Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):511-6.

PMID:3911145
Abstract

We describe a rapid and accurate high performance liquid chromatographic (HPLC) method for vancomycin quantitation. This method is then compared with two immunoassays, RIA and FPIA. The chemical extraction step needed for HPLC is simple and rapid. Both conventional reversed phase HPLC and high speed reversed phase HPLC were tested. The mobile phase was a mixture of aqueous ammonium acetate and acetonitrile. Specificity of the HPLC assay was good. Serum levels in 112 clinical specimens assayed by HPLC were regressed against the levels obtained for the same samples by both RIA and FPIA. The correlation was good (RIA : r = 0.945; FPIA : r = 0.967). Considering the disadvantages of RIA, HPLC and FPIA emerge as the methods of choice.

摘要

我们描述了一种用于万古霉素定量的快速、准确的高效液相色谱(HPLC)方法。然后将该方法与两种免疫测定法,即放射免疫测定法(RIA)和荧光偏振免疫测定法(FPIA)进行比较。HPLC所需的化学提取步骤简单且快速。对传统反相HPLC和高速反相HPLC都进行了测试。流动相是醋酸铵水溶液和乙腈的混合物。HPLC测定法的特异性良好。通过HPLC测定的112份临床标本中的血清水平与通过RIA和FPIA对相同样本测得的水平进行回归分析。相关性良好(RIA:r = 0.945;FPIA:r = 0.967)。考虑到RIA的缺点,HPLC和FPIA成为首选方法。

相似文献

1
[HPLC, RIA, FPIA. Evaluation of 3 methods for the assay of vancomycin].[高效液相色谱法、放射免疫分析法、荧光偏振免疫分析法。万古霉素测定3种方法的评估]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):511-6.
2
Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.雅培TDx荧光偏振免疫分析法、山德士放射免疫分析法及高效液相色谱法测定血清环孢素的比较
Transplant Proc. 1988 Apr;20(2 Suppl 2):345-7.
3
Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.荧光偏振免疫分析法对万古霉素降解产物CDP-1的交叉反应性的潜在问题:在肾功能受损患者血清中的检测
Ther Drug Monit. 1989 Sep;11(5):585-91.
4
The TDx assay for cyclosporine and its metabolites in blood samples compared with HPLC and RIA methods.
Drugs Exp Clin Res. 1989;15(4):185-8.
5
Comparison of fluorescence polarization immunoassay and high-performance liquid chromatography methods for assay of teicoplanin: can correlation be improved?
Pathol Biol (Paris). 2004 Dec;52(10):584-8. doi: 10.1016/j.patbio.2004.07.033.
6
Comparison of cyclosporin A measurement in whole blood by six different methods.
J Clin Chem Clin Biochem. 1990 Jan;28(1):53-7.
7
Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.万古霉素五种检测方法的实验室评估:生物测定法、高压液相色谱法、荧光偏振免疫测定法、放射免疫测定法和荧光免疫测定法。
J Clin Microbiol. 1984 Sep;20(3):311-6. doi: 10.1128/jcm.20.3.311-316.1984.
8
Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.建立用于治疗药物监测的去甲万古霉素荧光偏振免疫分析方法。
J Antibiot (Tokyo). 2012 Jan;65(1):35-9. doi: 10.1038/ja.2011.89. Epub 2011 Nov 2.
9
[Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].[采用高压液相色谱法(HPLC)对接受甲氨蝶呤(MTX)治疗的患者进行血清甲氨蝶呤(MTX)和7-羟基甲氨蝶呤浓度监测,并比较HPLC法与荧光偏振免疫分析法(FPIA)测定的血清MTX水平]
Gan To Kagaku Ryoho. 1991 Jun;18(7):1119-25.
10
Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay.
Ther Drug Monit. 1991 Nov;13(6):511-7.